Latest News of CLSD
Clearside Biomedical Inc (CLSD) Q3 2024 Earnings Call Highlights: Promising Clinical Trial ...
By Yahoo! Finance |
19 hours ago
The feedback from the AAO meeting on the study design incorporating retreatment with aflibercept was positive. The flexibility was well-received, aligning with physician needs....
Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years
By Yahoo! Finance |
3 days ago
Despite Clearside Biomedical, Inc.'s recent 13% share price increase, its three-year returns show a significant decline of 77%. The company's revenue has been shrinking by 38% annually, impacting its ...